Infected Hematopoietic Stem Cells and with Integrated HBV DNA Generate Defective T Cells in Chronic HBV Infection Patients
Overview
Affiliations
A weak T-cell response plays a key role in the persistence of hepatitis B virus (HBV) infection. We aimed to confirm that T-cell defects in patients with chronic HBV infection are associated with HBV DNA infection of bone marrow (BM) hematopoietic stem cells (HSCs). Using reverse transcription polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH), we observed the transcription of HBsAg coding genes and confirmed the integration of HBV DNA in CD34(+) BM HSCs from chronic HBV infection patients. T cells were generated by coculturing the HSCs with delta-like ligand 1-expressing OP9 (OP9-DL1) cells. The phenotypes of the T cells were then evaluated by flow cytometric (FACS) analysis on days 14 and 25. The results demonstrated that fewer CD3(+) TCRaβ(+) CD3(+) CD4(+) and CD4(+) CD8(+) T cells were generated from the HSCs of the patients than from the healthy controls, (P < 0.01) but the frequency of CD3(+) D8(+) T cells was not significantly different between the two group (P > 0.05). In contrast, CD4(+) CD25(+) T cells were more in the patient group than in healthy controls (P < 0.01) on both days 14 and 25. There were fewer CD3(+) CD4(+) /CD3(+) CD8(+) cells in the patient group than in the healthy control group on day 25 (P < 0.05). Less proliferation and lower levels of IL-2 and IFN- γ were also observed in the patient group compared with the control group (P < 0.05).These data suggest that HBV DNA infected and integrated into the BM HSCs from patients with chronic HBV infection and that these BM HSCs generated defective T cells.
The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma.
Li W, Wang S, Jin Y, Mu X, Guo Z, Qiao S Front Microbiol. 2024; 15:1469016.
PMID: 39309526 PMC: 11412822. DOI: 10.3389/fmicb.2024.1469016.
New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis.
Svicher V, Salpini R, DAnna S, Piermatteo L, Iannetta M, Malagnino V Front Oncol. 2023; 13:1143258.
PMID: 37007163 PMC: 10050604. DOI: 10.3389/fonc.2023.1143258.
Salpini R, DAnna S, Benedetti L, Piermatteo L, Gill U, Svicher V Front Microbiol. 2022; 13:972687.
PMID: 36118192 PMC: 9478028. DOI: 10.3389/fmicb.2022.972687.
Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis.
Coffin C, Mulrooney-Cousins P, Michalak T Front Microbiol. 2021; 12:695384.
PMID: 34421849 PMC: 8377760. DOI: 10.3389/fmicb.2021.695384.
Lau K, Burak K, Coffin C Microorganisms. 2020; 8(10).
PMID: 32987867 PMC: 7599633. DOI: 10.3390/microorganisms8101470.